| 1. | schachererjm | |
| 2. | kungfuninjaninja | |
| 3. | juliomuneca476 | |
| 4. | cwhitebiz | |
| 5. | 296brenda44 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | kungfuninjaninja 05/06/2018 Anyone? |
| 2. | juliomuneca476 05/18/2018 Positive drug update for ADVM-022 macular degeneration treatment |
| 3. | cwhitebiz 08/27/2018 Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema |
| 4. | kungfuninjaninja 05/01/2018 Adverum Biotechnologies Announces Long-term Preclinical Efficacy Data on ADVM-022 Gene Therapy in Wet AMD |
| 5. | schachererjm 02/15/2018 I have never even heard of these guys |
| 6. | kungfuninjaninja 08/09/2018 Reports Q2 EPS loss of $0.30 and revenue of $0.49M (+6.5% Y/Y) |
| 7. | schachererjm 02/12/2018 Adverum Biotechnologies Announces Closing of $69 Million Public Offering |
| 8. | schachererjm 02/07/2018 Commenced an underwritten public offering of its common stock |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Adverum Biotechnologies, Inc.
- ADVM
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.